文献速递肿瘤 PET/CT

前列腺癌患者肝炎性假瘤表现为FDG高摄取肝病灶:PET/CT诊断陷阱

Hepatic Inflammatory Pseudotumor Presenting as FDG-avid Liver Lesions in a Prostate Cancer Patient: A Diagnostic Pitfall on PET/CT.
PubMed 文献 · Clin Nucl Med · 2026-06-17

70岁前列腺癌患者因新发肝病灶行18F-FDG PET/CT,双病灶呈不均匀高代谢,结合CT疑为肝转移并行手术切除,病理意外证实为肝炎性假瘤。PSA低于生化复发阈值而CRP升高,提示炎症可能干扰PET/CT判读。

要点

  • 前列腺癌患者新发FDG高摄取肝病灶需鉴别炎性假瘤,避免误判为转移。
  • PSA低于生化复发阈值而CRP升高时,应警惕炎症性病变可能。
  • FDG高代谢并非恶性肿瘤特异,病理是确诊肝炎性假瘤的关键。

核心结论

  • 肝炎性假瘤可表现为FDG高摄取肝病灶,在前列腺癌患者中易被误诊为肝转移。

研究设计与样本

  • 本文为单例病例报告,描述一名70岁前列腺癌患者的诊断与治疗经过。

主要发现

  • 增强CT新发现两个疑为转移的肝病灶,18F-FDG PET/CT示双病灶不均匀摄取增高。
  • 患者PSA低于生化复发阈值,而C反应蛋白升高。
  • 基于CT和FDG高代谢疑为肝局限转移并手术切除,组织病理学意外证实为肝炎性假瘤。

临床怎么用

  • 前列腺癌患者出现FDG高摄取肝病灶时,应结合PSA和CRP等炎症指标综合判断,必要时行病理确诊。

局限性

  • 单例病例报告,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 70-year-old man with prostate cancer underwent contrast-enhanced CT for lesion characterization, which revealed two newly detected hepatic lesions suspicious for metastasis. The prostate-specific antigen level remained below the threshold for biochemical recurrence, whereas C-reactive protein was elevated. 18 F-FDG PET/CT was performed for metabolic characterization and whole-body evaluation, demonstrating heterogeneous increased uptake in both lesions. On the basis of the CT findings and FDG hypermetabolism, liver-confined metastatic disease was suspected, and surgical resection was performed. Histopathology unexpectedly revealed a hepatic inflammatory pseudotumor.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Weng Y, Yin H, Shi H, et al. Hepatic Inflammatory Pseudotumor Presenting as FDG-avid Liver Lesions in a Prostate Cancer Patient: A Diagnostic Pitfall on PET/CT. Clin Nucl Med. 2026. PMID: 42302736. doi:10.1097/RLU.0000000000006529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。